Clinical trials for Exotics specialty
The investigators hypothesize that it is possible to establish squamous cell carcinoma (SCC) cell lines from tumors originating from non-domestic species. The objective of this study is to establish primary cell lines for avian SCC. The investigators predict that establishment of these cell lines is an important step to better identifying viable treatment options for this tumor in birds.
Birds diagnosed with squamous cell carcinoma.
Birds that have not been diagnosed with squamous cell carcinoma.
Clients will receive a discount on services if they participate in this study.
Jennifer Graham, DVM, Dipl. ABVP (Avian / Exotic Companion Mammal), Dipl. ACZM
Our aims are to determine if removal of the ovaries or entire reproductive tract after removal of fibroadenomas (tumor) in rats will prevent or delay development of a new fibroadenoma at the same or at a distant location.
With mammary tumors being the most common reason pet rats present to clinical practice, this project has the potential to impact all rat owners and their pet rats. This project may also be useful to the laboratory animal community since ovariectomy or ovariohystectomy at the time of fibroadenoma removal and impact on recurrence of fibroadenomas has not been investigated in laboratory rats.
Rats will be 6 months to 2.5 years old and weigh 150 grams to 350 grams
Rats will be intact females presenting with masses suspected to be mammary fibroadenoma.
Rats should otherwise be assessed as healthy and able to undergo routine surgery.
All rats will receive histologic examination (under the microscope) of their tumors at no charge once the study is funded.
Any surgical procedures (including spay, ovariectomy, and mass removals) are charged under an established package price that includes anesthesia, surgery, and hospitalization.
Your pet’s participation will also allow us to gain information that will help in the treatment of other rats with this condition. You understand that your animal’s participation in this study may not alleviate or cure his/her ailment.
For questions regarding the clinical trial please email the clinical trials technician, Diane Welsh at: firstname.lastname@example.org